Intranasal Epitope‐Polymer Vaccine Lodges Resident Memory T Cells Protecting Against Influenza Virus
Open Access
- 9 March 2024
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13 (15) , e2304188
Abstract
Intranasal vaccines, unlike injectable vaccines, boost immunity along the respiratory tract; this can significantly limit respiratory virus replication and shedding. There remains a need to develop mucosal adjuvants and vaccine delivery systems that are both safe and effective following intranasal administration. Here, biopolymer particles (BP) densely coated with repeats of MHC class I restricted immunodominant epitopes derived from influenza A virus namely NP366, a nucleoprotein‐derived epitope and PA224, a polymerase acidic subunit derived epitope, are bioengineered. These BP‐NP366/PA224 can be manufactured at a high yield and are obtained at ≈93% purity, exhibiting ambient‐temperature stability. Immunological characterization includes comparing systemic and mucosal immune responses mounted following intramuscular or intranasal immunization. Immunization with BP‐NP366/PA224 without adjuvant triggers influenza‐specific CD8+ T cell priming and memory CD8+ T cell development. Co‐delivery with the adjuvant poly(I:C) significantly boosts the size and functionality of the influenza‐specific pulmonary resident memory CD8+ T cell pool. Intranasal, but not intramuscular delivery of BP‐NP366/PA224 with poly(I:C), provides protection against influenza virus challenge. Overall, the BP approach demonstrates as a suitable antigen formulation for intranasal delivery toward induction of systemic protective T cell responses against influenza virus.Keywords
Funding Information
- Griffith University
- Australian Research Council (DP200100874, DP220102236)
This publication has 71 references indexed in Scilit:
- Synthetic Particulate Subunit Vaccines for the Prevention of Q FeverAdvanced Healthcare Materials, 2024
- Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective ImmunityAdvanced Healthcare Materials, 2021
- Polymeric nanoparticle vaccines to combat emerging and pandemic threatsBiomaterials, 2021
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2Cell, 2020
- Repeated Antigen Exposure Extends the Durability of Influenza-Specific Lung-Resident Memory CD8+ T Cells and Heterosubtypic ImmunityCell Reports, 2018
- Physicochemical characterization of nanomaterials: polymorph, composition, wettability, and thermal stability2018
- Bioengineering towards self-assembly of particulate vaccinesCurrent Opinion in Biotechnology, 2017
- Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infectionHeliyon, 2017
- Nanoparticles target distinct dendritic cell populations according to their sizeEuropean Journal of Immunology, 2008
- A sensitive, viable-colony staining method using Nile red for direct screening of bacteria that accumulate polyhydroxyalkanoic acids and other lipid storage compoundsArchives of Microbiology, 1999